Comparative in-vitro quality assessment of Risperidone Tablets marketed in Kaduna State, Nigeria.

Contenu principal de l'article

Rukayyat Bukola Oloyede
Aminu Musa
Lukman Mustapha
Olanike Catherine Poyi

Résumé

Approximately 1% of the world population develops psychosis during their lifetime. Risperidone, a benzisoxazole derivative, has been found to be effective in the management of psychosis especially in refractory psychotic patients with minimal side effects. This has contributed to its widespread use, resulting in the emergence of numerous generic brands. A comparative in-vitro quality assessment was carried out on four generic brands (A, B, C and D) and the innovator brand (E) of 2 mg risperidone tablets. Tests on uniformity of weight, friability, disintegration, dissolution and assay were carried out on the five brands and the result of the generics was compared with that of the innovator. The innovator brand passed all the tests. The generic brands passed the uniformity of weight, friability and disintegration tests, not exceeding the acceptable limits (BP, 2009). Only brand A failed the assay with a percentage content of 46 %. Brands C and D were found to have dissolution differencefactors within the accepted range of 0-10 %, but their similarity factors fell outside the acceptable range of 50-100 %. Brands A and B failed the dissolution tests entirely. This suggests that some of the generics of risperidone tablets marketed in Kaduna fall below the acceptable specifications.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Renseignements sur l'article

Comment citer
Oloyede, R. B., Musa, A., Mustapha, L., & Poyi, O. C. (2020). Comparative in-vitro quality assessment of Risperidone Tablets marketed in Kaduna State, Nigeria. Nigerian Journal of Pharmaceutical and Applied Science Research, 8(1), 32–37. Consulté à l’adresse http://mail.nijophasr.net/index.php/nijophasr/article/view/273
Rubrique
Articles
Bibliographies de l'auteur-e

Rukayyat Bukola Oloyede

Department of Pharmaceutical and Medicinal Chemistry, Kaduna State University, Kaduna, Nigeria

Aminu Musa

Department of Pharmaceutical and Medicinal Chemistry, Ahmadu Bello University, Zaria, Kaduna, Nigeria

Lukman Mustapha

Department of Pharmaceutical and Medicinal Chemistry, Kaduna State University, Kaduna, Nigeria

Olanike Catherine Poyi

Department of Pharmaceutical and Medicinal Chemistry, University of Jos, Jos, Nigeria

Références

Benjamin, J. W., Christopher, D. E., Andrew, S. F., Susan. J., Richard, E. K., Terra, G. L., Robbe, C. L., Terry, W. M., Larry, K. R., Anjanette, P. S., John, A. S., Kimberly, D. S., Duckhee, Y. T., Anna, M. W. and Lucinda, F. B. (2005).Assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques.International Journal of Pharmaceutics, 306: 56–70.

Birhanu, G., Hymete, A., Debellav, A. and Ashenef, A. (2014). Quality evaluation of the commonly prescribed antipsychotic drugs (chlorpromazine & thioridazine tablets) marketed in Ethiopia. International journal of pharmaceutical science research, 5(7): 3031-3041.

British Pharmacopoeia (2009). Appendix XII A. Disintegration test for tablets and capsules; 1-2.

Gupta, M. M. and Gupta, M. (2016). Comparative in-vitro pharmaceutical quality control evaluations of different brands of ibuprofen tablets marketed in the Trinidad & Tobago, West Indies, World journal of pharmacy and pharmaceutical sciences, 5(4): 2325-2334.

Hardman, J.G., Limburd, L.E., and Gilman, A.G. (Eds) (2000). The pharmacological basis of therapeutics 10th ed. McGraw-Hill, New York. Pp. 279.

Hoen, E. (2010). The revised drug strategy In: Access to essential medicines, intellectual property, and the World Health Organization. Krikprian, G. and Kapczynski, A. (Eds), Zone Books, New York, pp. 127-140.

Idris, A.Y., Usman M.A., Musa A., and Oloyede, R.B. (2015). Spectrophotometric determination of risperidone in pure and tablet dosage forms by formation of a coloured ion-pair complex with bromocresol green, Nigerian journal of scientific research, 14(1): 41-46.

Jim, K. (2005). Counterfeit prescription drugs a global problem: World Health Organization warns of international health and safety hazards. (http://www.renewamerica.com/columns/kouri/050722). Accessed on 23/10/ 2018.

Shah, V.P., Tsong, Y. and Sathe, P. (1998). In vitro dissolution profile comparison- statistics and analysis of similarity factor, f2. Pharmaceutical research, 15: 889-896.

Taylor, R. B., Shakoor, O., Behrens, R. H., Everard, M., Low. A. S.,Wangboonskul, J., Reid, R. G. and Kolawole, J. A. (2000).

Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. The Lancet, 357: 1933–1936.

United State Pharmacopoeia (2006). National Formulary, US Pharmacopieal convention Inc, MD,32(4): 1109.

Wondemagegnehu, E. (1999) Counterfeit and substandard drugs in Myanmar and Vietnam, essential drugs and other medicines. Geneva: World Health organization WHO/EDM/QSM/99; 3: 1-5.